These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23573360)

  • 1. An intravenous (i.v.) route-compatible formulation of FL118, a survivin, Mcl-1, XIAP, and cIAP2 selective inhibitor, improves FL118 antitumor efficacy and therapeutic index (TI).
    Ling X; Li F
    Am J Transl Res; 2013; 5(2):139-54. PubMed ID: 23573360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity.
    Ling X; Cao S; Cheng Q; Keefe JT; Rustum YM; Li F
    PLoS One; 2012; 7(9):e45571. PubMed ID: 23029106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of FL118, a survivin, Mcl-1, XIAP, and cIAP2 selective inhibitor, is highly dependent on its primary structure and steric configuration.
    Zhao J; Ling X; Cao S; Liu X; Wan S; Jiang T; Li F
    Mol Pharm; 2014 Feb; 11(2):457-67. PubMed ID: 24329001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kras mutation subtypes distinctly affect colorectal cancer cell sensitivity to FL118, a novel inhibitor of survivin, Mcl-1, XIAP, cIAP2 and MdmX.
    Thangaiyan R; Aljahdali IA; Lent-Moore KY; Liao J; Ling X; Li F
    Am J Transl Res; 2021; 13(7):7458-7474. PubMed ID: 34377229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity?
    Li F; Ling X; Harris DL; Liao J; Wang Y; Westover D; Jiang G; Xu B; Boland PM; Jin C
    Am J Cancer Res; 2017; 7(2):370-382. PubMed ID: 28337384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer drug FL118 is more than a survivin inhibitor: where is the Achilles' heel of cancer?
    Li F
    Am J Cancer Res; 2014; 4(3):304-11. PubMed ID: 24959385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FL118, a novel camptothecin analogue, overcomes irinotecan and topotecan resistance in human tumor xenograft models.
    Ling X; Liu X; Zhong K; Smith N; Prey J; Li F
    Am J Transl Res; 2015; 7(10):1765-81. PubMed ID: 26692923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer.
    Santha S; Ling X; Aljahdali IAM; Rasam SS; Wang X; Liao J; Wang J; Fountzilas C; Li Q; Qu J; Li F
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33217967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer.
    Ling X; Wu W; Fan C; Xu C; Liao J; Rich LJ; Huang RY; Repasky EA; Wang X; Li F
    J Exp Clin Cancer Res; 2018 Oct; 37(1):240. PubMed ID: 30285798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S; McGuire JJ; Rustum YM
    Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties.
    Wang J; Liu Z; Zhang D; Liu R; Lin Q; Liu J; Yang Z; Ma Q; Sun D; Zhou X; Jiang G
    Am J Transl Res; 2017; 9(8):3676-3686. PubMed ID: 28861158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance.
    Westover D; Ling X; Lam H; Welch J; Jin C; Gongora C; Del Rio M; Wani M; Li F
    Mol Cancer; 2015 Apr; 14():92. PubMed ID: 25928015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FL118 induces p53-dependent senescence in colorectal cancer cells by promoting degradation of MdmX.
    Ling X; Xu C; Fan C; Zhong K; Li F; Wang X
    Cancer Res; 2014 Dec; 74(24):7487-97. PubMed ID: 25512388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FL118 Enhances Therapeutic Efficacy in Colorectal Cancer by Inhibiting the Homologous Recombination Repair Pathway through Survivin-RAD51 Downregulation.
    Kim J; Jeong Y; Shin YM; Kim SE; Shin SJ
    Cancers (Basel); 2024 Oct; 16(19):. PubMed ID: 39410005
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-Activity Relationship of FL118 Platform Position 7 Versus Position 9-Derived Compounds and Their Mechanism of Action and Antitumor Activity.
    Wang W; Ling X; Wang R; Xiong H; Hu L; Yang Z; Wang H; Zhang Y; Wu W; Singh PK; Wang J; Li F; Li Q
    J Med Chem; 2023 Dec; 66(24):16888-16916. PubMed ID: 38100041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts.
    Cao S; Durrani FA; Rustum YM
    Clin Cancer Res; 2004 Apr; 10(7):2561-9. PubMed ID: 15073137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FL118: A potential bladder cancer therapeutic compound targeting H2A.X identified through library screening.
    Fan G; Luo X; Shi Y; Wang Y; Ji L; Gong Y; Yang E; Chen C; Cui S; Ding H; Zhang Z; Wang J; Liu Y; Wang Z
    Bioorg Chem; 2024 Dec; 153():107802. PubMed ID: 39244972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple mechanisms involved in a low concentration of FL118 enhancement of AMR-MeOAc to induce pancreatic cancer cell apoptosis and growth inhibition.
    Rabi T; Li F
    Am J Cancer Res; 2018; 8(11):2267-2283. PubMed ID: 30555743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FL118 inhibits viability and induces apoptosis of colorectal cancer cells via inactivating the CIP2A/PP2A axis.
    Lin X; Gao M; Zhang A; Tong J; Zhang X; Su Q; Yang Z; Gao H; Jiang G
    Life Sci; 2019 Dec; 239():117074. PubMed ID: 31751585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyroptosis is involved in the inhibitory effect of FL118 on growth and metastasis in colorectal cancer.
    Tang Z; Ji L; Han M; Xie J; Zhong F; Zhang X; Su Q; Yang Z; Liu Z; Gao H; Jiang G
    Life Sci; 2020 Sep; 257():118065. PubMed ID: 32659366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.